JP2011517683A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517683A5 JP2011517683A5 JP2011503961A JP2011503961A JP2011517683A5 JP 2011517683 A5 JP2011517683 A5 JP 2011517683A5 JP 2011503961 A JP2011503961 A JP 2011503961A JP 2011503961 A JP2011503961 A JP 2011503961A JP 2011517683 A5 JP2011517683 A5 JP 2011517683A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- unsubstituted
- alkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RCINICONZNJXQF-VAZQATRQSA-N CC(C)([C@@](C1)([C@H](C([C@]2([C@@H](C[C@@H]3O)OC2)OC(C)=O)[C@]3(C)C([C@@H]2OC(C)=O)=O)OC(c3ccccc3)=O)O)C2=C(C)[C@H]1OC([C@@H]([C@H](c1ccccc1)NC(c1ccccc1)=O)O)=O Chemical compound CC(C)([C@@](C1)([C@H](C([C@]2([C@@H](C[C@@H]3O)OC2)OC(C)=O)[C@]3(C)C([C@@H]2OC(C)=O)=O)OC(c3ccccc3)=O)O)C2=C(C)[C@H]1OC([C@@H]([C@H](c1ccccc1)NC(c1ccccc1)=O)O)=O RCINICONZNJXQF-VAZQATRQSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4400608P | 2008-04-10 | 2008-04-10 | |
| US61/044,006 | 2008-04-10 | ||
| PCT/US2008/076179 WO2009126175A1 (en) | 2008-04-10 | 2008-09-12 | Compositions of hydrophobic taxane derivatives and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011517683A JP2011517683A (ja) | 2011-06-16 |
| JP2011517683A5 true JP2011517683A5 (https=) | 2012-10-18 |
Family
ID=40456809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011503961A Pending JP2011517683A (ja) | 2008-04-10 | 2008-09-12 | 疎水性タキサン誘導体の組成物およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2011517683A (https=) |
| KR (2) | KR20150136137A (https=) |
| RU (1) | RU2010145529A (https=) |
| TW (1) | TW200942233A (https=) |
| WO (1) | WO2009126175A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| LT3311805T (lt) | 2005-08-31 | 2020-04-27 | Abraxis Bioscience, Llc | Kompozicijos, apimančios silpnai vandenyje tirpius farmacinius agentus ir priešmikrobinius agentus |
| PT2419732T (pt) | 2009-04-15 | 2019-12-24 | Abraxis Bioscience Llc | Composições e métodos de nanopartículas isentas de priões |
| US9211283B2 (en) * | 2009-12-11 | 2015-12-15 | Biolitec Pharma Marketing Ltd | Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| NZ602382A (en) | 2010-03-26 | 2014-11-28 | Abraxis Bioscience Llc | Methods of treatment of hepatocellular carcinoma |
| EP3141245A1 (en) | 2010-03-29 | 2017-03-15 | Abraxis BioScience, LLC | Methods of treating cancer |
| MX2012011155A (es) | 2010-03-29 | 2012-12-05 | Abraxis Bioscience Llc | Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos. |
| MX347225B (es) | 2010-06-04 | 2017-04-19 | Abraxis Bioscience Llc * | Metodos de tratamiento contra el cancer pancreatico. |
| JP6031437B2 (ja) | 2010-06-07 | 2016-11-24 | アブラクシス バイオサイエンス， エルエルシー | 増殖性疾患を処置するための組み合わせ療法 |
| EP2447268A1 (en) * | 2010-10-29 | 2012-05-02 | INDENA S.p.A. | Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III |
| TW201700103A (zh) | 2011-11-01 | 2017-01-01 | 西建公司 | 利用胞嘧啶核苷類似物之口服配方治療癌症的方法 |
| WO2013085902A1 (en) | 2011-12-05 | 2013-06-13 | The University Of Texas M.D. | Combination therapy methods for treating an inflammatory breast cancer |
| EP3560486A1 (en) | 2011-12-14 | 2019-10-30 | Abraxis BioScience, LLC | Use of polymeric excipients for lyophilization or freezing of particles |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| EP3698784A1 (en) | 2013-03-12 | 2020-08-26 | Abraxis BioScience, LLC | Methods of treating lung cancer |
| RU2015143490A (ru) | 2013-03-14 | 2017-04-26 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения рака мочевого пузыря |
| WO2015195634A1 (en) | 2014-06-17 | 2015-12-23 | Celgne Corporation | Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| ES3009356T3 (en) | 2015-06-29 | 2025-03-26 | Abraxis Bioscience Llc | Nanoparticles comprising sirolimus and an albumin for use in treating epithelioid cell tumors |
| ES3055492T3 (en) * | 2015-09-16 | 2026-02-12 | Dfb Soria Llc | Delivery of drug nanoparticles and methods of use thereof |
| EP3706750A1 (en) | 2017-11-06 | 2020-09-16 | RAPT Therapeutics, Inc. | Chemokine receptor modulators for treatment of epstein barr virus positive cancer |
| IL277402B1 (en) | 2018-03-20 | 2026-04-01 | Abraxis Bioscience Llc | Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin |
| BR112022007710A2 (pt) | 2019-10-28 | 2022-07-12 | Abraxis Bioscience Llc | Composições farmacêuticas de albumina e rapamicina |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| NZ262679A (en) * | 1993-02-22 | 1997-08-22 | Vivorx Pharmaceuticals Inc | Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell |
| US6749868B1 (en) * | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| ATE309235T1 (de) * | 1995-09-12 | 2005-11-15 | Zeneus Pharma Ltd | Hydrolyse-einleitende hydrophobe taxane derivate |
| PT1023050E (pt) * | 1997-06-27 | 2013-12-04 | Abraxis Bioscience Llc | Novas formulações de agentes farmacológicos, métodos para a sua preparação e métodos para a sua utilização |
| NZ514406A (en) * | 2000-02-02 | 2005-01-28 | Univ Florida State Res Found | C10 heterosubstituted acetate taxanes as antitumor agents |
| US20090130163A1 (en) * | 2005-02-18 | 2009-05-21 | Abraxis Bio Scoence, Inc. | Drugs With Improved Hydrophobicity For Incorporation in Medical Devices |
| JP2008531591A (ja) * | 2005-02-24 | 2008-08-14 | エラン・ファルマ・インターナショナル・リミテッド | ドセタキセルおよびそれらの類似体のナノ粒子製剤 |
-
2008
- 2008-09-12 TW TW097135271A patent/TW200942233A/zh unknown
- 2008-09-12 WO PCT/US2008/076179 patent/WO2009126175A1/en not_active Ceased
- 2008-09-12 JP JP2011503961A patent/JP2011517683A/ja active Pending
- 2008-09-12 RU RU2010145529/15A patent/RU2010145529A/ru unknown
- 2008-09-12 KR KR1020157031393A patent/KR20150136137A/ko not_active Ceased
- 2008-09-12 KR KR1020107025259A patent/KR20100133475A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011517683A5 (https=) | ||
| RU2010145529A (ru) | Композиции гидрофобных производных таксана и их применение | |
| US20250120947A1 (en) | Compounds and methods to sensitize cancer cells to cisplatin | |
| TWI316942B (en) | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents | |
| US12318364B2 (en) | Isoflavonoid compositions and methods for the treatment of cancer | |
| AU2009308511B2 (en) | Transition metal complexes of a bis[thiohydrazide amide] compound | |
| JP2019510787A5 (https=) | ||
| JP2019522055A5 (https=) | ||
| RU2019142507A (ru) | Композиции, способы и системы для синтеза и применение визуализирующих средств | |
| JP2013519653A5 (https=) | ||
| JP2015508068A5 (https=) | ||
| KR20170141757A (ko) | 테트라하이드로나프티리디닐 프로피온산 유도체 및 이의 용도 | |
| JP2013518036A5 (https=) | ||
| US9072660B2 (en) | Topical itraconazole formulations and uses thereof | |
| JP2017537886A5 (https=) | ||
| EP3922251B1 (en) | Cancer immunotheraphy adjuvant | |
| RU2012150501A (ru) | Противораковые стероидные лактоны, ненасыщенные в положении 7(8) | |
| JP2015500294A (ja) | 金属過剰症を治療する経口製剤 | |
| JP2017515899A5 (https=) | ||
| WO2017004005A1 (en) | N-acylalkyl prodrugs of multi-tyrosine kinase inhibitors and methods of use | |
| FR3056108A1 (fr) | Utilisation des harringtonines dans le traitement cancer du sein, notamment triple-negatif | |
| CN107108761B (zh) | 硫酸软骨素衍生物和膀胱疾病处置剂 | |
| US9376432B2 (en) | Use of VEGFR-3 inhibitors for treating hepatocellular carcinoma | |
| JP2019505571A5 (https=) | ||
| JP2011506393A5 (https=) |